Kura
Kyowa Kirin Invests $330M in Kura’s Leukemia Drug, Gaining Shared Rights Ahead of FDA Submission
Kyowa Kirin, Kura, leukemia drug, FDA submission, pharmaceutical investment
Actionable Insights Powered by AI
Kyowa Kirin, Kura, leukemia drug, FDA submission, pharmaceutical investment